Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Lung cancer is the leading cause of cancer mortality worldwide with 1.8 million newly diagnosed cases, or 13% of all cancers diagnosed, in 2012 [1]. The worldwide numbers are still rising despite an ongoing small decline in the Western world. Global statistics estimate that 15% of lung cancers in men and 53% in women are not attributable to smoking, overall accounting for 25% [2].